194 related articles for article (PubMed ID: 28468089)
21. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.
Teruya-Feldstein J; Chiao E; Filippa DA; Lin O; Comenzo R; Coleman M; Portlock C; Noy A
Ann Oncol; 2004 Nov; 15(11):1673-9. PubMed ID: 15520070
[TBL] [Abstract][Full Text] [Related]
22. Epidemiologic Characteristics, Treatment Patterns, and Survival Analysis of Plasmablastic Lymphoma in the United States: A SEER and NCDB Analysis.
Hansen AR; Vardell VA; Fitzgerald LA
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e152-e160.e3. PubMed ID: 38262787
[TBL] [Abstract][Full Text] [Related]
23. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases.
Li YJ; Li JW; Chen KL; Li J; Zhong MZ; Liu XL; Yi PY; Zhou H
Blood Res; 2020 Mar; 55(1):49-56. PubMed ID: 32269975
[TBL] [Abstract][Full Text] [Related]
24. Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder.
Liu F; Asano N; Tatematsu A; Oyama T; Kitamura K; Suzuki K; Yamamoto K; Sakamoto N; Taniwaki M; Kinoshita T; Nakamura S
Histopathology; 2012 Dec; 61(6):1183-97. PubMed ID: 22958176
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
[TBL] [Abstract][Full Text] [Related]
26. Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease.
Guerrero-Garcia TA; Mogollon RJ; Castillo JJ
Leuk Res; 2017 Nov; 62():12-16. PubMed ID: 28963907
[TBL] [Abstract][Full Text] [Related]
27. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N
Blood; 2024 Jan; 143(2):152-165. PubMed ID: 37832030
[TBL] [Abstract][Full Text] [Related]
28. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
[TBL] [Abstract][Full Text] [Related]
30. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin G; Butera JN
Leuk Lymphoma; 2010 Nov; 51(11):2047-53. PubMed ID: 20919850
[TBL] [Abstract][Full Text] [Related]
31. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
32. [Plasmablastic lymphoma].
Fernández-Álvarez R; Sancho JM; Ribera JM
Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
[TBL] [Abstract][Full Text] [Related]
33. MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry.
Pather S; Mashele T; Willem P; Patel M; Perner Y; Motaung M; Nagiah N; Waja F; Philip V; Lakha A; Hale MJ
Histopathology; 2021 Jul; 79(1):86-95. PubMed ID: 33450085
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
[TBL] [Abstract][Full Text] [Related]
35. Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases.
Meer S; Perner Y; Willem P
J Oral Pathol Med; 2022 Feb; 51(2):146-151. PubMed ID: 34910327
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Hess BT; Giri A; Park Y; Patel KK; Link BK; Nowakowski GS; Maliske SM; Fortin S; Chavez JC; Saeed H; Hill BT; Mejia Garcia AV; Maddocks KJ; Hanel W; Wagner-Johnston ND; Messmer MR; Kahl BS; Watkins M; Alderuccio JP; Lossos IS; Nathan S; Orellana-Noia VM; Portell CA; Landsburg DJ; Ayers EC; Castillo JJ
Am J Hematol; 2023 Feb; 98(2):300-308. PubMed ID: 36588409
[TBL] [Abstract][Full Text] [Related]
37. Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma.
Al Tabaa Y; Tchernonog E; Faurie P; Cottereau AS; Monjanel H; Bonnet A; Le Gouill S; Gyan E; Ghesquieres H; Mariano-Goulart D; Cartron G
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1705-1709. PubMed ID: 29679112
[TBL] [Abstract][Full Text] [Related]
38. [Plasmablastic lymphoma: a clinicopathologic analysis of 11 cases with review of literature].
Li F; Ding W; Zuo Z; Geng N; Yang H; Liu X; Wang J; Yao W; Liu W
Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):37-42. PubMed ID: 26791552
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review.
Lin L; Zhang X; Dong M; Li L; Wang X; Zhang L; Fu X; Sun Z; Wu J; Li Z; Chang Y; Wang Y; Zhou Z; Zhang M; Chen Q
Medicine (Baltimore); 2017 Feb; 96(7):e6171. PubMed ID: 28207555
[TBL] [Abstract][Full Text] [Related]
40. Survival analysis in treated plasmablastic lymphoma patients: a population-based study.
Florindez JA; Alderuccio JP; Reis IM; Lossos IS
Am J Hematol; 2020 Nov; 95(11):1344-1351. PubMed ID: 32777103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
